As the uveitogenic potentialof CRALBP has already been demonstrated in two different experimental animalspecies [1], this againmeets the Witebsky’s postulates and suggests CRALBP as a trueautoantigen for human autoimmune uveitis, accomplishing the third postulate. This evidence concerns the gene RLBP1 and autoimmune uveitis.